These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7404579)

  • 1. Increased excretion of fecal fat in hyperlipidemic patients.
    Nagasaki A; Maruhama Y
    Tohoku J Exp Med; 1980 May; 131(1):99-100. PubMed ID: 7404579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen catabolism in patients with type II and type IV hyperlipidemia. Effect of dietary and clofibrate treatment on laboratory findings.
    Fletcher A; Alkjaersig N; Schonfeld G; Witztum J
    Arteriosclerosis; 1981; 1(3):202-9. PubMed ID: 7295193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatty acid metabolism in primary hyperlipoproteinemia].
    Reuter W
    Z Gesamte Inn Med; 1979 Oct; 34(20):suppl 287-9. PubMed ID: 398634
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of plasma and biliary lipids in hyperlipoproteinaemia.
    Leijd B
    Acta Med Scand Suppl; 1979; 635():1-32. PubMed ID: 295570
    [No Abstract]   [Full Text] [Related]  

  • 5. Similar serum lipoprotein reductions by lipid-lowering diets with different polyunsaturated:saturated fat values.
    Gustafsson IB; Boberg J; Karlström B; Lithell H; Vessby B
    Br J Nutr; 1983 Nov; 50(3):531-7. PubMed ID: 6639917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ciprofibrate in primary type II and IV hyperlipidemia: the Italian multicenter study.
    Cattin L; Da Col PG; Feruglio FS; Finazzo L; Rimondi S; Descovich G; Manzato E; Zambon S; Crepaldi G; Siepi D
    Clin Ther; 1990; 12(6):482-8. PubMed ID: 2289217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)].
    Loeper J; Goy-Loeper J; Rouffy J
    Clin Chim Acta; 1979 Oct; 98(1-2):19-26. PubMed ID: 227624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid content of gallbladder bile and stones in type IIb and IV hyperlipoproteinemia.
    Greco AV; Mingrone G; Passi S
    Clin Chim Acta; 1981 Oct; 116(1):81-9. PubMed ID: 7318176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J; Martorell J
    Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Fat Tolerance Test for Sitosterolemia and Familial Hypercholesterolemia: A Study Protocol.
    Nomura A; Tada H; Nohara A; Kawashiri MA; Yamagishi M
    J Atheroscler Thromb; 2018 Aug; 25(8):741-746. PubMed ID: 29353827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Artery; 1980; 8(2):113-9. PubMed ID: 7458676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of fat-rich versus carbohydrate-rich diets on bile acid kinetics, biliary lipids, and net steroid balance in hyperlipidemic subjects.
    Andersén E; Hellström K
    Metabolism; 1980 May; 29(5):400-9. PubMed ID: 6990177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cholic acid feeding on bile acid kinetics and neutral fecal steroid excretion in hyperlipoproteinemia (types II and IV).
    Einarsson K; Hellström K; Kallner M
    Metabolism; 1974 Sep; 23(9):863-73. PubMed ID: 4851615
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholesterol balance and fecal neutral steroid and bile acid excretion in normal men fed dietary fats of different fatty acid composition.
    Connor WE; Witiak DT; Stone DB; Armstrong ML
    J Clin Invest; 1969 Aug; 48(8):1363-75. PubMed ID: 5796351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sterol excretion with polyunsaturated-fat high-cholesterol diets.
    Nestel PJ; Havenstein N; Homma Y; Scott TW; Cook LJ
    Metabolism; 1975 Feb; 24(2):189-98. PubMed ID: 1113682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of unsaturated fats and cholesterol on serum and fecal lipids. A study of healthy middle-aged men.
    Hill P; Reddy BS; Wynder EL
    J Am Diet Assoc; 1979 Oct; 75(4):414-20. PubMed ID: 479483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat containing stearic acid increases fecal neutral steroid excretion and catabolism of low density lipoproteins without affecting plasma cholesterol concentration in hamsters fed a cholesterol-containing diet.
    Imaizumi K; Abe K; Kuroiwa C; Sugano M
    J Nutr; 1993 Oct; 123(10):1693-702. PubMed ID: 8410360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal cholesterol excretion studies in type II hypercholesterolemic patients treated with the soybean protein diet.
    Fumagalli R; Soleri L; Farina R; Musanti R; Mantero O; Noseda G; Gatti E; Sirtori CR
    Atherosclerosis; 1982 Jun; 43(2-3):341-53. PubMed ID: 6889431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.